Beckman Coulter’s Alzheimer’s blood test obtains CE mark
July 7, 2026
Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.
Beckman Coulter’s assay is used to measure phosphorylated tau (pTau217) levels in the blood of individuals displaying signs of cognitive decline.
A new “tumor-on-a-chip” model is giving scientists a live look at how pancreatic cancer can recruit the body’s own immune cells to help tumors survive.
What happens to the human body in space may help scientists create new anti-aging therapies.
Parkinson’s disease (PD) is the second most common form of neurodegenerative disease and afflicts more than 10 million people worldwide.
Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute and Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions.
The Technical University of Munich (TUM) has developed a soft, pneumatic glove that restores the ability of people with paralyzed hands to grasp object
In recent years, notable advances have been made in diagnosing and treating breast cancer. However, its recurrence continues to plague thousands, deepening the need to find ways to better predict the likelihood of its return.
A paper published in the journal Biomarker Research by a cross-university team led by Queen Mary University of London researchers validates the use of a noninvasive brush biopsy test that can detect oral cancer within one hour.
A new artificial intelligence model called COMPASS, developed by Harvard Medical School researchers and their colleagues, improves prediction of which patients are most likely to respond to ICIs.
The CE marking by GMED recognises compliance with patient safety and clinical efficacy for Class IIb devices.